Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

68.37 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Tesla Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript ↗
EXAS earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Will EXACT SCIENCES CORP breakout? ↗
With a solid technical rating of 8 out of 10, EXACT SCIENCES CORP (NASDAQ:EXAS) is showing strong indications of a possible breakout. 
Via Chartmill
News headline image
Deep Dive Into Exact Sciences Stock: Analyst Perspectives (7 Ratings) ↗
 
Via Benzinga
News headline image
(EXAS) - Analyzing Exact Sciences's Short Interest ↗
 
Via Benzinga
News headline image
Exact Sciences Stock Plummets After Worse-Than-Expected Q3 Results, FY24 Guidance Below Estimates ↗
Exact Sciences shares are dropping after the company reported its third-quarter results after Tuesday's closing bell. Here's a look at the details. 
Via Benzinga
News headline image
Can This Beaten-Down Cathie Wood Stock Bounce Back? ↗
An updated version of Exact Sciences' key product just got regulatory approval. That could help the healthcare stock stage a comeback. 
Via The Motley Fool
News headline image
FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test ↗
Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in... 
Via Benzinga
News headline image
Exact Sciences Stock Rises After FDA Signs Off On New Cologuard ↗
The company is soon to launch its next-generation colon cancer screening tool. 
Via Investor's Business Daily
News headline image
Analyst Ratings For Exact Sciences ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Cracking The Code: Understanding Analyst Reviews For Exact Sciences ↗
 
Via Benzinga
News headline image
Exact Sciences Analysts Slash Their Forecasts After Q2 Results ↗
 
Via Benzinga
News headline image
Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? ↗
These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also raised price targets for Applovin and Arm Holdings. 
Via Benzinga
News headline image
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) 
Via News Direct
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights ↗
 
Via Benzinga
News headline image
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio? ↗
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H.... 
Via Benzinga
News headline image
Crude Oil Moves Lower; Moderna Shares Plunge ↗
 
Via Benzinga
News headline image
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July ↗
 
Via Benzinga
Topics Stocks
News headline image
Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat ↗
The company expects stronger second-half sales vs. the first half of 2024. 
Via Investor's Business Daily
News headline image
Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript ↗
EXAS earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Exact Sciences Stock Climbs After Strong Q2 Results ↗
Exact Sciences shares are trading higher after the company reported its second-quarter financial results Wednesday. Here's a look at the details from the report: 
Via Benzinga
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions. 
Via The Motley Fool
News headline image
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption ↗
FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-approved blood test as a primary CRC screening option. Shield meets Medicare... 
Via Benzinga
News headline image
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns ↗
The investment banking firm says these companies are among the best stocks to buy and have some strong tailwinds behind them. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.